155 related articles for article (PubMed ID: 34695225)
21. Evaluation of two software using Bayesian methods for monitoring exposure and dosing once-daily intravenous busulfan in paediatric patients receiving haematopoietic stem cell transplantation.
Lawson R; Paterson L; Fraser CJ; Hennig S
Cancer Chemother Pharmacol; 2021 Sep; 88(3):379-391. PubMed ID: 34021809
[TBL] [Abstract][Full Text] [Related]
22. Limited sampling strategy for predicting busulfan exposure in hematopoietic stem cell transplantation recipients.
Huang JJ; Chen B; Hu J; Yang WH
Int J Clin Pharm; 2017 Aug; 39(4):662-668. PubMed ID: 28555420
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of oral busulfan in young Japanese children before hematopoietic stem cell transplantation.
Nakamura H; Sato T; Okada K; Miura G; Ariyoshi N; Nakazawa K; Kitada M
Ther Drug Monit; 2008 Feb; 30(1):75-83. PubMed ID: 18223466
[TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
[TBL] [Abstract][Full Text] [Related]
25. Development of a pharmacokinetic and Bayesian optimal sampling model for individualization of oral busulfan in hematopoietic stem cell transplantation.
Bullock JM; Smith PF; Booker BM; Loughner J; Capozzi D; McCarthy PL; Shaw LM
Ther Drug Monit; 2006 Feb; 28(1):62-6. PubMed ID: 16418695
[TBL] [Abstract][Full Text] [Related]
26. Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing.
Bartelink IH; Boelens JJ; Bredius RG; Egberts AC; Wang C; Bierings MB; Shaw PJ; Nath CE; Hempel G; Zwaveling J; Danhof M; Knibbe CA
Clin Pharmacokinet; 2012 May; 51(5):331-45. PubMed ID: 22455797
[TBL] [Abstract][Full Text] [Related]
27. External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients.
Qin Y; Jiao Z; Ye YR; Shen Y; Chen Z; Chen YT; Li XY; Lv QZ
J Glob Antimicrob Resist; 2023 Dec; 35():347-353. PubMed ID: 37573945
[TBL] [Abstract][Full Text] [Related]
28. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
Brooks E; Tett SE; Isbel NM; Staatz CE
Clin Pharmacokinet; 2016 Nov; 55(11):1295-1335. PubMed ID: 27138787
[TBL] [Abstract][Full Text] [Related]
29. The use of pharmacokinetic models in paediatric onco-haematology: effects on clinical outcome through the examples of busulfan and cyclosporine.
Bleyzac N
Fundam Clin Pharmacol; 2008 Dec; 22(6):605-8. PubMed ID: 19049662
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT.
Ben Hassine K; Seydoux C; Khier S; Daali Y; Medinger M; Halter J; Heim D; Chalandon Y; Schanz U; Nair G; Cantoni N; Passweg JR; Satyanarayana Uppugunduri CR; Ansari M
Transplant Cell Ther; 2024 Mar; 30(3):332.e1-332.e15. PubMed ID: 38081414
[TBL] [Abstract][Full Text] [Related]
31. Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization.
McCune JS; Bemer MJ; Barrett JS; Scott Baker K; Gamis AS; Holford NH
Clin Cancer Res; 2014 Feb; 20(3):754-63. PubMed ID: 24218510
[TBL] [Abstract][Full Text] [Related]
32. Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients.
de Castro FA; Piana C; Simões BP; Lanchote VL; Della Pasqua O
Br J Clin Pharmacol; 2015 Oct; 80(4):618-29. PubMed ID: 25819742
[TBL] [Abstract][Full Text] [Related]
33. Population Pharmacokinetic Model of Intravenous Busulfan in Hematopoietic Cell Transplantation: Systematic Review and Comparative Simulations.
Takahashi T; Jaber MM; Brown SJ; Al-Kofahi M
Clin Pharmacokinet; 2023 Jul; 62(7):955-968. PubMed ID: 37415003
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic behavior and appraisal of intravenous busulfan dosing in infants and older children: the results of a population pharmacokinetic study from a large pediatric cohort undergoing hematopoietic stem-cell transplantation.
Paci A; Vassal G; Moshous D; Dalle JH; Bleyzac N; Neven B; Galambrun C; Kemmel V; Abdi ZD; Broutin S; Pétain A; Nguyen L
Ther Drug Monit; 2012 Apr; 34(2):198-208. PubMed ID: 22406655
[TBL] [Abstract][Full Text] [Related]
35. Intra-individual Pharmacokinetic Variability of Intravenous Busulfan in Hematopoietic Stem Cell-Transplanted Children.
Marsit H; Philippe M; Neely M; Rushing T; Bertrand Y; Ducher M; Leclerc V; Guitton J; Bleyzac N; Goutelle S
Clin Pharmacokinet; 2020 Aug; 59(8):1049-1061. PubMed ID: 32157629
[TBL] [Abstract][Full Text] [Related]
36. Individualizing oral busulfan dose after using a test dose in patients undergoing hematopoietic stem cell transplantation: pharmacokinetic characterization.
Effting C; de Moraes Arantes A; Queiroz Labre LV; Carneiro WJ; de Oliveira Neto JR; Bariani C; Rodrigues CR; Rodrigues AR; Cunha LC
Ther Drug Monit; 2015 Feb; 37(1):66-70. PubMed ID: 25588069
[TBL] [Abstract][Full Text] [Related]
37. Iron Chelation With Deferasirox Increases Busulfan AUC During Conditioning Chemotherapy Prior to Allogeneic Stem Cell Transplantation.
Essmann S; Dadkhah A; Janson D; Wolschke C; Ayuk F; Kröger NM; Langebrake C
Transplant Cell Ther; 2022 Feb; 28(2):115.e1-115.e5. PubMed ID: 34775147
[TBL] [Abstract][Full Text] [Related]
38. Busulfan dose Recommendation in Inherited Metabolic Disorders: Population Pharmacokinetic Analysis.
Takahashi T; Illamola SM; Jennissen CA; Long SE; Lund TC; Orchard PJ; Gupta AO; Long-Boyle JR
Transplant Cell Ther; 2022 Feb; 28(2):104.e1-104.e7. PubMed ID: 34883294
[TBL] [Abstract][Full Text] [Related]
39. Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study.
Zhang L; Liu M; Qin W; Shi D; Mao J; Li Z
Front Pharmacol; 2023; 14():1228641. PubMed ID: 37869748
[No Abstract] [Full Text] [Related]
40. Performance of Busulfan Dosing Guidelines for Pediatric Hematopoietic Stem Cell Transplant Conditioning.
Zao JH; Schechter T; Liu WJ; Gerges S; Gassas A; Egeler RM; Grunebaum E; Dupuis LL
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1471-8. PubMed ID: 25977229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
